搜索筛选:
搜索耗时0.1134秒,为你在为你在102,285,761篇论文里面共找到 11 篇相符的论文内容
类      型:
[期刊论文] 作者:Xiao-Jun Qian,Ren-You Zhai,Din, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2006
瞄准:为了评估本地肿瘤的用途,治疗为恶意的妨碍的胆汁的疾病把胆汁的排水(PTBD ) 与经皮的 transhepatic 相结合。方法:有恶意的胆汁的阻塞的 233 个病人的一个总数被金属性的...
[期刊论文] 作者:Xiao-Jun Qian,Ren-You Zhai,Din, 来源:世界胃肠病学杂志(英文版) 年份:2004
AIM: To evaluate the utility of local tumor therapy combined with percutaneous transhepatic biliary drainage (PTBD) for malignant obstructive biliary disease.ME...
[期刊论文] 作者:Xiao-Jun Qian,Ren-You Zhai,Ding-Ke Dai,Ping Yu,Li Gao, 来源:世界胃肠病学杂志(英文版) 年份:2006
AIM: To evaluate the utility of local tumor therapy combined with percutaneous transhepatic biliary drainage (PTBD) for malignant obstructive biliary disease.ME...
[期刊论文] 作者:Shi Qun-li,Jin Xing-zao,Zhou Xiao-jun,Qian Yuan-cheng,Shi Qin, 来源:中华医学杂志英文版 年份:1991
[期刊论文] 作者:Shan Ke,Xue-Mei Ding,Xiao-Jun Qian,Yi-Ming Zhou,Bao-Xin Cao,Kun Gao,Wen-Bing Sun,, 来源:World Journal of Gastroenterology 年份:2013
AIM:To investigate whether an ablative margin(AM)>1.0 cm might reduce chance of recurrence for patients with hepatocellular carcinoma(HCC)tumors 3.1to 5.0 cm in...
[期刊论文] 作者:Jun Gao,Xue-Mei Ding,Shan Ke,Yi-Ming Zhou,Xiao-Jun Qian,Rui-Liang Ma,Chun-Min Ning,Zong-Hai Xin,Wen-Bing, 来源:World Journal of Gastroenterology 年份:2004
阜阳市局 £4a 局长——_MINtkMMtgj’#lnH$B——q.M——D收束志不他只邀狲位J则【科校为先导推动地租工作.B为广为戳民U用凶盼引眯B.习.互们羹宽.互狈槽竺汹IAn.刊 办好杂志。必...
[会议论文] 作者:Fen Yang,Rong Deng,Xiao-Jun Qian,Xiao-Qi Wu,Juan Qin,Ting Sun,Gong-Kan Feng,Xiao-Feng Zhu,Shao-Hua Chang, 来源:2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议 年份:2013
[会议论文] 作者:Fen Yang,Xiao-Feng Zhu,Rong Deng,Shao-Hua Chang,Xiao-Jun Qian,Xiao-Qi Wu,Juan Qin,Ting Sun,Gong-Kan Feng, 来源:2012医学科学前沿暨第二届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份:2012
The serine/threonine kinase AKT is generally accepted as a promising anticancer therapeutic target.However,the relief of feedback inhibition and enhancement of other survival pathways often attenuate...
[会议论文] 作者:Fen Yang,Rong Deng,Shao-Hua Chang,Xiao-Jun Qian,Xiao-Qi Wu,Juan Qin,Ting Sun,Gong-Kan Feng,Ke Ding,Xiao-Feng, 来源:2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议 年份:2013
The serine/threonine kinase AKT is generally accepted as a promising anticancer therapeutic target.However,relief of feedback inhibition and enhancement of other survival pathways often attenuate anti...
[会议论文] 作者:Ke Din,Xiao-Feng Zhu,Jiao Ji,Rong Deng,Jun Tang,Fen Yang,Gong-Kan Feng,Wen-Dan Chen,Xiao-Qi Wu,Xiao-Jun Qian, 来源:2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份:2014
Side population (SP) cells in human nasopharyngeal carcinoma (NPC) are known to be enriched for cancer stem-like cells (CSLCs) and are the main cause of drug-resistance and tumor metastasis.In this st...
[会议论文] 作者:Xiao-jun Qian,Wen-Dan Chen,Gong-Kan Feng,Xiao-Feng Zhu,Yun-tian Li,Yan Yu,Yang Fen,Rong Deng,Jiao Ji,, 来源:2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份:2014
Dual PI3K/mTOR(phosphatidylinositol 3-kinase/mammalian target of rapamycin) inhibitors are being evaluated clinically for the treatment of tumors with a hyperactivated PI3K/mTOR pathway.However, unexp...
相关搜索: